KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bionano Genomics (BNGO) Change in Accured Expenses (2017 - 2025)

Bionano Genomics (BNGO) has disclosed Change in Accured Expenses for 9 consecutive years, with $522000.0 as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses rose 195.6% to $522000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$580000.0 through Dec 2025, up 74.06% year-over-year, with the annual reading at -$580000.0 for FY2025, 74.06% up from the prior year.
  • Change in Accured Expenses hit $522000.0 in Q4 2025 for Bionano Genomics, down from $721000.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $3.5 million in Q3 2022 to a low of -$5.3 million in Q2 2024.
  • Historically, Change in Accured Expenses has averaged -$50650.0 across 5 years, with a median of -$465500.0 in 2022.
  • Biggest five-year swings in Change in Accured Expenses: soared 680.11% in 2021 and later plummeted 1073.1% in 2022.
  • Year by year, Change in Accured Expenses stood at -$145000.0 in 2021, then tumbled by 1073.1% to -$1.7 million in 2022, then crashed by 105.11% to -$3.5 million in 2023, then skyrocketed by 84.35% to -$546000.0 in 2024, then surged by 195.6% to $522000.0 in 2025.
  • Business Quant data shows Change in Accured Expenses for BNGO at $522000.0 in Q4 2025, $721000.0 in Q3 2025, and -$1.3 million in Q2 2025.